Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
Geethadevi, Anjali, Nair, Ajay, Parashar, Deepak, Ku, Zhiqiang, Xiong, Wei, Deng, Hui, Li, Yongsheng, George, Jasmine, McAllister, Donna M, Sun, Yunguang, Kadamberi, Ishaque P, Gupta, Prachi, Dwinell, Michael B, Bradley, William H, Rader, Janet S, Rui, Hallgeir, Schwabe, Robert F, Zhang, Ningyan, Pradeep, Sunila, An, Zhiqiang, Chaluvally-Raghavan, Pradeep
Published in Cancer research (Chicago, Ill.) (15.10.2021)
Published in Cancer research (Chicago, Ill.) (15.10.2021)
Get full text
Journal Article
Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance
Parashar, Deepak, Geethadevi, Anjali, Mittal, Sonam, McAlarnen, Lindsey A, George, Jasmine, Kadamberi, Ishaque P, Gupta, Prachi, Uyar, Denise S, Hopp, Elizabeth E, Drendel, Holli, Bishop, Erin A, Bradley, William H, Bone, Kathleen M, Rader, Janet S, Pradeep, Sunila, Chaluvally-Raghavan, Pradeep
Published in Cancers (01.02.2022)
Published in Cancers (01.02.2022)
Get full text
Journal Article
Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14 , 958
Parashar, Deepak, Geethadevi, Anjali, Mittal, Sonam, McAlarnen, Lindsey A, George, Jasmine, Kadamberi, Ishaque P, Gupta, Prachi, Uyar, Denise S, Hopp, Elizabeth E, Drendel, Holli, Bishop, Erin A, Bradley, William H, Bone, Kathleen M, Rader, Janet S, Pradeep, Sunila, Chaluvally-Raghavan, Pradeep
Published in Cancers (16.05.2022)
Published in Cancers (16.05.2022)
Get full text
Journal Article
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
Banerjee, Susana, Moore, Kathleen N, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S, Gourley, Charlie, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William H, Holmes, Eileen, Lowe, Elizabeth S, DiSilvestro, Paul
Published in The lancet oncology (01.12.2021)
Published in The lancet oncology (01.12.2021)
Get full text
Journal Article
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
González-Martín, Antonio, Pothuri, Bhavana, Vergote, Ignace, DePont Christensen, René, Graybill, Whitney, Mirza, Mansoor R, McCormick, Colleen, Lorusso, Domenica, Hoskins, Paul, Freyer, Gilles, Baumann, Klaus, Jardon, Kris, Redondo, Andrés, Moore, Richard G, Vulsteke, Christof, O’Cearbhaill, Roisin E, Lund, Bente, Backes, Floor, Barretina-Ginesta, Pilar, Haggerty, Ashley F, Rubio-Pérez, Maria J, Shahin, Mark S, Mangili, Giorgia, Bradley, William H, Bruchim, Ilan, Sun, Kaiming, Malinowska, Izabela A, Li, Yong, Gupta, Divya, Monk, Bradley J
Published in The New England journal of medicine (19.12.2019)
Published in The New England journal of medicine (19.12.2019)
Get full text
Journal Article
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial
DiSilvestro, Paul, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S, Gourley, Charlie, Banerjee, Susana, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol A, Bradley, William H, Mathews, Cara A, Liu, Joyce, Lowe, Elizabeth S, Bloomfield, Ralph, Moore, Kathleen N
Published in Journal of clinical oncology (20.10.2020)
Published in Journal of clinical oncology (20.10.2020)
Get full text
Journal Article
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial
Friedlander, Michael, Moore, Kathleen N, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Lisyanskaya, Alla, Sonke, Gabe S, Gourley, Charlie, Banerjee, Susana, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William H, Liu, Joyce, Mathews, Cara, Selle, Frédéric, Lortholary, Alain, Lowe, Elizabeth S, Hettle, Robert, Flood, Emuella, Parkhomenko, Elena, DiSilvestro, Paul
Published in The lancet oncology (01.05.2021)
Published in The lancet oncology (01.05.2021)
Get full text
Journal Article
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial
Colombo, Nicoletta, Moore, Kathleen, Scambia, Giovanni, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S., Gourley, Charlie, Banerjee, Susana, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William H., Kim, Jae-Weon, Mathews, Cara, Liu, Joyce, Lowe, Elizabeth S., Bloomfield, Ralph, DiSilvestro, Paul
Published in Gynecologic oncology (01.10.2021)
Published in Gynecologic oncology (01.10.2021)
Get full text
Journal Article
GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study
Thaker, Premal H, Bradley, William H, Leath, 3rd, Charles A, Gunderson Jackson, Camille, Borys, Nicholas, Anwer, Khursheed, Musso, Lauren, Matsuzaki, Junko, Bshara, Wiam, Odunsi, Kunle, Alvarez, Ronald D
Published in Clinical cancer research (15.10.2021)
Published in Clinical cancer research (15.10.2021)
Get full text
Journal Article
Considerations for pharmacologic thromboprophylaxis following inpatient brachytherapy for gynecologic malignancies
McAlarnen, Lindsey A., Small, Christina, Tostrud, Lauren, Pan, Amy Y., Erickson, Beth, Bedi, Meena, Bradley, William H.
Published in Brachytherapy (01.09.2023)
Published in Brachytherapy (01.09.2023)
Get full text
Journal Article
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
O'Cearbhaill, Roisin E., Pérez-Fidalgo, Jose-Alejandro, Monk, Bradley J., Tusquets, Ignacio, McCormick, Colleen, Fuentes, Jose, Moore, Richard G., Vulsteke, Christof, Shahin, Mark S., Forget, Frédéric, Bradley, William H., Hietanen, Sakari, O'Malley, David M., Dørum, Anne, Slomovitz, Brian M., Baumann, Klaus, Selle, Frédéric, Calvert, Paula M., Artioli, Grazia, Levy, Tally, Kumar, Aalok, Malinowska, Izabela A., Li, Yong, Gupta, Divya, González-Martín, Antonio
Published in Gynecologic oncology (01.07.2022)
Published in Gynecologic oncology (01.07.2022)
Get full text
Journal Article
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer – An NRG oncology/Gynecologic Oncology Group study
von Gruenigen, Vivian E, Huang, Helen Q, Beumer, Jan H, Lankes, Heather A, Tew, William, Herzog, Thomas, Hurria, Arti, Mannel, Robert S, Rizack, Tina, Landrum, Lisa M, Rose, Peter G, Salani, Ritu, Bradley, William H, Rutherford, Thomas J, Higgins, Robert V, Secord, Angeles Alvarez, Fleming, Gini
Published in Gynecologic oncology (01.03.2017)
Published in Gynecologic oncology (01.03.2017)
Get full text
Journal Article
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study
Thaker, Premal H., Brady, William E., Lankes, Heather A., Odunsi, Kunle, Bradley, William H., Moore, Kathleen N., Muller, Carolyn Y., Anwer, Khursheed, Schilder, Russell J., Alvarez, Ronald D., Fracasso, Paula M.
Published in Gynecologic oncology (01.11.2017)
Published in Gynecologic oncology (01.11.2017)
Get full text
Journal Article
Effect of physician gender and specialty on utilization of hysterectomy in New York, 2001–2005
Gretz, Herbert, MD, Bradley, William H., MD, Zakashansky, Konstantin, MD, Nezhat, Farr, MD, Bohren, Deborah Loeb, Kreiger, Kenneth, PhD, Rubin, Elizabeth, Sokolow, Alan, MD
Published in American journal of obstetrics and gynecology (01.10.2008)
Published in American journal of obstetrics and gynecology (01.10.2008)
Get full text
Journal Article
Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer
Eng, Kevin H, Hanlon, Bret M, Bradley, William H, Szender, J. Brian
Published in Gynecologic oncology (01.11.2015)
Published in Gynecologic oncology (01.11.2015)
Get full text
Journal Article
Patient clinical factors influencing use of hysterectomy in New York, 2001–2005
Gretz, Herbert, MD, Bradley, William H., MD, Zakashansky, Konstantin, MD, Nezhat, Farr, MD, Rahaman, Jamal, MD, Chuang, Linus, MD, Bohren, Deborah Loeb, MPA, Kreiger, Kenneth, PhD, Rubin, Elizabeth, MPA, Sokolow, Alan, MD
Published in American journal of obstetrics and gynecology (01.10.2008)
Published in American journal of obstetrics and gynecology (01.10.2008)
Get full text
Journal Article
Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
von Gruenigen, Vivian E., Huang, Helen Q., Cella, David, Zevon, MichaelA, LaChance, Jason A., Walker, Joan L., Salani, Ritu, Modesitt, Susan C., Morris, Robert T., Bradley, William H., Boente, Matthew P., Wenzel, Lari
Published in Gynecologic oncology (01.07.2018)
Published in Gynecologic oncology (01.07.2018)
Get full text
Journal Article
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study
Wenzel, Lari, Huang, Helen Q., Cella, David, McKinney, Chelsea O., Zevon, Michael A., LaChance, Jason A., Walker, Joan L., Salani, Ritu, Modesitt, Susan C., Morris, Robert T., Bradley, William H., Boente, Matthew P., von Gruenigen, Vivian E.
Published in Gynecologic oncology (01.11.2021)
Published in Gynecologic oncology (01.11.2021)
Get full text
Journal Article